Back to HCMView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Advanced Intrahepatic Cholangiocarcinoma
View Full LandscapeDrug Information
Target Indication
Advanced Intrahepatic Cholangiocarcinoma
Clinical Trial
NCT04353375Last updated: 1/1/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
fruquintinibPhase 3
Advanced Endometrial Cancer
Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and GemcitabinePhase 3
Metastatic Pancreatic Cancer
fruquintinib+sintilimabPhase 3
Advanced Renal Cell Carcinoma
HMPL-306 RegimenPhase 3
Acute Myeloid Leukemia
Fruquintinib in Combination with SintilimabPhase 2
Advanced Solid Tumor
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts